← Back to Compounds
injectableanabolic

Stenbolone Acetate

AnatrofinStenanbol
267
Anabolic Ratio
53
Androgenic Ratio
2d
Half-Life

2-methyl-5α-dihydrotestosterone derivative (injectable). Mildly anabolic with low androgenic activity and no aromatization. Produces lean, dry gains similar to Primobolan. Historically marketed in Spain (Anatrofin) and Italy. Now extremely rare but still discussed in harm-reduction circles for its clean side-effect profile.

Mechanism of Action

DHT-derived with 2-methyl modification enhancing AR binding. Cannot aromatize. 5α-reduced structure means no further metabolism to more potent androgen. Acetate ester gives short half-life requiring frequent injections. Very limited modern pharmacokinetic data.

Stenbolone Acetate molecule
Molecular structure

Typical Dosing

100 mg
low / week
200 mg
moderate / week
400 mg
high / week

⚠ Warning Flags

  • Extremely rare — nearly all product is counterfeit
  • Requires every-other-day injection (short half-life)

Effect Profile

Muscle Protein Synthesis
4Low
Nitrogen Retention
4Low
Strength Gains
4Low
Red Blood Cell Production
2Minimal
Fat Loss
4Low
Glycogen Storage
3Low
Recovery Speed
4Low
Collagen Synthesis
3Low

Side Effect Profile

Hormonal Suppression
3Low
Estrogenic Effects
1Minimal
Androgenic Effects
3Low
Cardiovascular Strain
3Low
Liver Stress
1Minimal
Insulin Resistance
1Minimal
Mood Changes
2Minimal
Prostate Risk
2Minimal

Research Studies

Pharmacology of anabolic steroids

Kicman AT. · 2008

PubMed

Review documents stenbolone's pharmacological classification as a mild DHT-derivative injectable with favorable anabolic:androgenic ratio; notes its obsolescence in clinical medicine despite an acceptable safety profile.